RKLB targets trimmed but 2 of 3 kept Overweight. 'Record bookings, higher Neutron pricing' from Barclays confirms Electron health and Neutron pricing power simultaneously. Neutron first flight de-risking is the re-rating trigger.
RKLB
RKLB
Investus Reports
๐ AnalysisRKLB2026.11.11 09:00
Rocket Lab โ 3 Houses Trim Targets After Q3 | Neutron Timing Is the Key Variable
RKLB Analysts
Member #22RKLB2d
โฅ 25 0
RKLB Discussion
View allA
Memberโ Member2dRKLB post-Q3: Cantor ($122โ$111), Barclays ($85โ$82), Piper ($83โ$58) all trimmed. But Cantor and Barclays kept Overweight โ long-term case intact. 'Record bookings, higher Neutron pricing' per Barclays. It all comes down to Neutron first flight timing
โฅ 27 0
